Comparative study of intralesional injection of triamcinolone versus placental extract in cases of oral submucous fibrosis
Keywords:Oral submucous fibrosis, Triamcinolone acetonide, Placental extract injection, Reduced mouth opening
Background: Oral submucous fibrosis (OSMF) is a common premalignant condition caused by chewing arecanut, betel quid and gutkha with tobacco. One of the important therapeutic modalities is intralesional injection therapy. The most commonly used intralesional agents are placental extract, corticosteroids and hyaluronidase.
Methods: Patients of OSMF (30) were randomly allocated and 15 patients were given 1 ml placental extract submucosally in each retromolar trigon weekly for 8 weeks and 15 patients were injected with 40 mg/ml of triamcinolone submucosally on each side weekly for 8 weeks. The mouth opening was measured as the inter-incisor distance by Vernier calliper at maximal active mouth opening by patient at initial visit and every follow up visit and recorded. Treatment outcome was evaluated on the basis of improvement in trismus, oral mucosal pattern and reduction in burning sensation.
Results: Out of 30 patients, 27 were males and 3 females. 16 patients (53.33%) were in the age group of 21-30 years. Most of patients in our study had complain of reduced mouth opening and inability to take spicy food which is 93.33% of cases followed by burning sensation in mouth 90%, oral ulceration 83.33%, dryness of mouth 30%, difficulty/pain in swallowing 13.33% and halitosis 2%. 60% of patients mouth opening was improved >10 mm with triamcinolone while in placental extract 26.6%. Symptomatic relief were obtained more with injection placental extract.
Conclusions: Triamcinolone injection has more improvement in mouth opening compared to placental extract. It was observed that injection placental extract gives good symptomatic relief in the major symptoms like burning sensation in mouth, inability to take spicy food, oral ulceration compared to injection triamcinolone.
Naik SM, Appaji MK, Goutham MK. Comparative study of intralesional triamcinolone acetonide and hyaluronidase Vs placental extract in 60 cases of oral submucous fibrosis. Indian J Head Neck Surg. 2012;3(2):59-65.
Angadi PV, Rekha K. Oral submucous fibrosis: a clinicopathologic review of 205 cases in Indians. Oral Maxillofacial Surg. 2011;15(1):15-9.
Pindborg J, Sirsat S. Oral submucous fibrosis. Oral Surgery, Oral.Medicine, And Oral Pathol. 1966;22(6):764-79.
Rajendran R. Oral submucous fibrosis: etiology, pathogenesis, and future research. Bulletin of the World Health Organization. 1994;72(6):985-96.
Karemore TV, Motwani M. Evaluation of the effect of newer antioxidant lycopene in the treatment of oral submucous fibrosis. Indian J Dent Res. 2012;23(6):524-8.
Khanna JN, Andrade NN. Oral submucous fibrosis: A new concept in surgical management Report of 100 cases. Int J Oral Maxillofac Surg. 1995;24:433-9.
Katharia SK, Singh SP, Kulshreshtha VK. The effects of placenta extract in management of oral submucous fibrosis. Indian J Pharmacol. 1992;24:181-3.
Filatov VP. Tissue Therapy: Teaching on Biogenic Stimulators. Moscow: Foreign Language Publishing House, 1955: 2.
Singh M, Niranjan HS, Mehrotra R, Sharma D, Gupta SC. Efficacy of hydrocortisoneacetate/ hyaluronidase vs triamci- nolone acetonide/ hyaluronidase in the treatment of OSMF: Indian J Med Res. 2010;131:665-9.
Aziz SR. Oral submucous fibrosis: An unusual disease. JNJ Dent Assoc. Spring. 1997;68(2):17-9.
Lai DR, Chen HR, Lin LM, Huang YL, Tsai CC. Clinical evaluation of different treatment methodsfor oral submucous fibrosis: A 10-year experience with 150 cases. J Oral Pathol Med. 1995;24:402-6.
Naik SM, Appaji MK, Ravishankara S, Goutham MK, Devi NP, Mushannavar AS, et al. Comparative Study of Intralesional Triamcinolone Acetonide and Hyaluronidase vs Placental Extract in 60 Cases Int J Head Neck Surg. 2012;3(2):59-65.
Leena James,Akshay Shetty, Diljith Rishi and Marin Abraham J International Oral Health, 2015;7(8):82-5.